Heery Christopher's Form 4 filing
Arcellx, Inc. (ACLX) · filed Jan 12, 2026
- Accession no.
- 0001193125-26-010889
- Filed
- Jan 12, 2026
- Trade date
- Jan 2-12, 2026
- Filing delay
- 10 daysLate
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions. Open-market sales total $393.3K. It was filed 10 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Heery ChristopherCIK 0001789632 | Officer (CHIEF MEDICAL OFFICER) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 2, 2026 | Common Stock | MOption exerciseAcquired | +13,021 | $0.00 | $0 | 13,615 | Direct | |
| Jan 12, 2026 | Common Stock | SSaleDisposed | −6,131 | $64.15F3 | −$393,303.65 | 37,068 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F3
Represents the weighted average share price of an aggregate total of 6,131 shares sold in the price range of $64.14112 to $64.4463 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.